- GLP-1 craze: Buy Baxter, skip Eli Lilly, strategist saysGLP-1 craze: Buy Baxter, skip Eli Lilly, strategist says (finance.yahoo)
- Something remarkable and extremely rare happened in the U.S. stock market on Monday (marketwatch)
- China vows to boost domestic demand in bid for 2024 recovery (cnbc)
- Airports will see their busiest holiday travel season on record, AAA projects (marketwatch)
- Macy’s real estate alone is worth nearly $3 billion more than investors’ bid, these analysts say (marketwatch)
- It’s Time to Get Excited About Banks. Here Are Four to Watch. (barrons)
- The Math for Buying a Home No Longer Works. These Charts Show You Why. (wsj)
- U.S. Companies Are Finding It Hard to Avoid China (wsj)
- Shohei the Time Value of Money (bloomberg)
- Fed to start cutting rates midyear in 2024 with high chance of soft landing, CNBC Fed survey finds (cnbc)
- Michael Milken says the Fed won’t move too early and risk massive inflation like the 1970s (cnbc)
- Soft-landing view has Ed Yardeni targeting 6,000 on the S&P 500 in two years (marketwatch)
